Skip to main content

Document language

Encontrados 1734543 resultado(s)
Encontradas 17346 página(s)

Single cell characterization of the circulating immune systemin Sjogren's Syndrome

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
G mez, AG, Corominas, H, Vicu a, RG, Gonzlez, MF, Melchor-D az, S, Casasempere, PV, Estrada-Alarc n, P, Tandaipan, JL, Castro, MF, Herrera, SMR, L pez, MR, Paredes-Romero, B, Mu oz, S, Lpez, M, Bra a, I, Bonilla, G, Almagro, RM, Manrique-Arija, S, Canamero, MB, L pez-N ez, L, Veiga, CG, Alegre-Sancho, JJ, de Salazar, JRG, Venegas, JJP, Font-Urgelles, J, Ivorra, JAR, Sequi-Sabater, JM, Ortega-Castro, R, Moriano, C, Manzano-Canabal, G, Peralta-Gin s, C, Narv ez, J, C liz-C liz, R, Mart nez-Ferrin, J, Bilbao, LS, Serrano-Benavente, B, Boix-Mart , N, Selles-Rius, A, P rez, M, Ca ete, J, Bala a, NP, Errico, DA, Guill n, Y, Galindo, JAP, Juli , A, Barril, SM, Andreu, JL




Patterns and Predictors of Clinical Improvement in Patients with Sjogren's Disease: A Longitudinal Analysis of ESSDAI and ESSPRI Improvements

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
G mez, AG, Mateu, SHM, Tandaipan, JL, Castro, MF, Gonzalez, G, Melchor-D az, S, Ecenarro, MU, Almagro, RM, Casasempere, PV, Paredes-Romero, B, Font-Urgelles, J, Estrada-Alarc n, P, Manrique-Arija, S, Ca amero, MAB, Moriano, C, Alegre-Sancho, JJ, L pez, MR, L pez, M, Bonilla, G, Ortega-Castro, R, Herrera, SMR, Bra a, I, L pez-Nu ez, L, Narv ez, J, de Salazar, JRG, L pez-S nchez, RD, Veiga, CG, Mart nez-Ferrin, J, Venegas, JJP, Manzano-Canabal, G, Peralta-Gin s, C, Bilbao, LSA, Ivorra, JAR, C liz-C liz, R, Serrano-Benavente, B, Fern ndez-Aguado, S, Boix-Marti, N, Kirkegaard-Biosca, E, Saez, IA, Selles-Rius, A, P rez, M, Ca ete, J, Marsal, S, Andreu, JL




Long-term sustainability and effectiveness of anti-CGRP monoclonal antibodies in migraine: 2-year results from the EUREkA cohort

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Caronna, E, Mas-de-les-Valls, R, Egeo, G, Vázquez, MM, Castellanos, CN, Portocarrero, L, Vaghi, G, Rodriguez-Montolio, J, Sanchez, AJ, Muñoz-Vendrell, A, Oliveira, R, Polanco, M, Osorio, YG, Canales, J, Sanahuja, J, Waliszewska-Prosól, M, Pereira, L, Layos-Romero, A, Luzeiro, I, Dorado, L, Escudero, MRA, Martins, IP, Sundal, C, Irimia, P, Ros, AL, Gago-Veiga, AB, Juanes, FV, Ruscheweyh, R, Sacco, S, García-Azorín, D, Gonzalez-Quintanilla, V, Gil-Gouveia, R, Huerta-Villanueva, M, Rodriguez-Vico, J, Santos-Lasaosa, S, Ghadiri-Sani, M, Tassorelli, C, Diaz-DeTeran, J, Insa, SD, Oria, CG, Barbanti, P, Pozo-Rosich, P




Is achieving higher standards in real-world migraine care feasible with anti-CGRP monoclonal antibodies preventive therapies?

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Caronna, E, Mas-de-les-Valls, R, Gabriella, E, Vázquez, MM, Castellanos, CN, Membrilla, J, Vaghi, G, Rodríguez-Montolio, J, Fabra, NF, Caballero, FS, Sanchez, AJ, Muñoz-Vendrell, A, Oliveira, R, Gárate, G, Osorio, YG, Ornello, R, Sanahuja, J, Cabral, G, Blasco, IB, Waliszewska-Prosól, M, Pereira, L, Layos-Romero, A, Luzeiro, I, Dorado, L, Escudero, MRA, May, A, López-Bravo, A, Martins, IP, Sundal, C, Irimia, P, Ros, AL, Gago-Veiga, AB, Juanes, FV, Ruscheweyh, R, Sacco, S, Cuadrado-Godia, E, García-Azorín, D, Pascual, J, Gil-Gouveia, R, Huerta-Villanueva, M, Rodriguez-Vico, J, Romero, JV, Obach, V, Santos-Lasaosa, S, Ghadiri-Sani, M, Tassorelli, C, de Terán, JD, Insa, SD, Oria, CG, Barbanti, P, Pozo-Rosich, P




Anifrolumab in Systemic Lupus Erythematosus. Spanish Multicenter Registry in Clinical Practice

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Calvo-R o, V, Secada-G mez, C, Guerrero, MR, Font-Urgelles, J, Casafont-Sol , I, Mayo-Juanatey, A, Alegre-Sancho, JJ, Freites, D, Martin, CH, Garrido, N, Arribas, GG, Sanchez, JRM, Garc a-Valle, A, Iba ez, M, Morillo, FL, Manzanares, AG, Sandoval-Moreno, S, Cort s-Hern ndez, J, Palma-Sanchez, D, Lojo-Oliveira, L, Cervantes, E, Ramos, PC, Larios, CA, Sala, L, Labrador-S nchez, E, Peralta-Gin s, C, Plaza-Aulestia, N, Onaindia, IU, Malone, MM, de Salazar, JRG, Corteguera, M, Cebrian, L, Pages, FA, Lamua-Riazuelo, JR, Canales, MDF, Hern ndez, MJA, Bufort, MG, Pamies, A, Sarabia, L, Aguirre-del-Pino, R, Lefler, JAC, Seijas, A, Carrasco-Cubero, C, Cofi o, ALC, Ortiz-Santamaria, V, Casta eda, S, Laino, M, Calvo, CO, Arconada, C, Urruticoechea-Arana, A, Garcia-Magallon, B, Alfaro, AVA, Rodriguez, SL, Olivares, MS, Villar, PL, Brandy, AM, Vilamajo, IR, Martos, AG, Magallares, B, Urmeneta, GS, Mart n, CC, Alonso, ER, Bejerano-Herreria, C, Blanco, R




Porto-sinusoidal vascular liver disorder with portal hypertension: Natural history and long-term outcome

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Magaz, M, Giudicelli-Lett, H, Abraldes, JG, Nicoara-Farcau, O, Turon, F, Rajoriya, N, Goel, A, Raymenants, K, Hillaire, S, Téllez, L, Elkrief, L, Procopet, B, Orts, L, Nery, F, Shukla, A, Larrue, H, Degroote, H, Aguilera, V, Llop, E, Turco, L, Indulti, F, Gioia, S, Tosetti, G, Bitto, N, Becchetti, C, Alvarado, E, Roig, C, Diaz, R, Praktiknjo, M, Konicek, AL, Olivas, P, Fortea, JI, Masnou, H, Puente, A, Ardèvol, A, Navascués, CA, Romero-Gutiérrez, M, Scheiner, B, Semmler, G, Mandorfer, M, Damiao, F, Baiges, A, Ojeda, A, Simón-Talero, M, González-Alayón, C, Díaz, A, García-Criado, A, De Gottardi, A, Hernández-Guerra, M, Genescà, J, Drilhon, N, Ferreira, CN, Reiberger, T, Rodríguez, M, Morillas, RM, Crespo, J, Trebicka, J, Bañares, R, Villanueva, C, Berzigotti, A, Primignani, M, La Mura, V, Riggio, O, Schepis, F, Verhelst, X, Calleja, JL, Bureau, C, Albillos, A, Nevens, F, Hernández-Gea, V, Tripathi, D, Rautou, PE, García-Pagán, JC

Background & Aims: Current knowledge of the natural history of patients with porto-sinusoidal vascular disorder (PSVD) is derived from small studies. The aim of the present study was to determine the natural history of PSVD and prognostic factors in a large multicenter cohort of patients. Methods: We performed a retrospective study on patients with PSVD and signs of portal hypertension (PH) prospectively registered in 27 centers. Results: A total of 587 patients were included, median age…



Tafasitamab, lenalidomide, and rituximab in relapsed or refractory follicular lymphoma (inMIND): a global, phase 3, randomised controlled trial.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sehn LH, Hübel K, Luminari S, Scholz CW, Salar A, Paneesha S, Wahlin BE, Panayiotidis P, Lee HP, Jiménez-Ubieto A, Sancho JM, Kim TM, Domingo Domenech E, Kumode T, Poh C, Thieblemont C, Deeren D, de Wit E, Arbushites M, Vassallo I, Trneny M

BACKGROUND: Follicular lymphoma is characterised by episodes of remission and relapse, with patients requiring multiple lines of therapy. Lenalidomide plus rituximab is a commonly used immunotherapy combination in patients with relapsed or refractory follicular lymphoma. We aimed to assess the efficacy and safety of adding tafasitamab, a CD19-targeted Fc-enhanced monoclonal antibody, to lenalidomide and rituximab in this setting. METHODS: This phase 3, double-blind, randomised, placebo…



Nivolumab added to cisplatin and radiotherapy versus cisplatin and radiotherapy alone after surgery for people with squamous cell carcinoma of the head and neck at a high risk of relapse (GORTEC 2018-01 NIVOPOST-OP): a randomised, open-label, phase 3 trial.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Bourhis J, Aupérin A, Borel C, Lefebvre G, Racadot S, Geoffrois L, Sun XS, Saada E, Cirauqui B, Rutkowski T, Henry S, Modesto A, Johnson A, Chapet S, Calderon B, Sire C, Malard O, Bainaud M, Da Silva Motta A, Thureau S, Pointreau Y, Blanchard P, Buiret G, Bozec L, Lopez S, Vanbockstael J, Bosset M, Greilsamer C, Daste A, Bruna A, N'Guyen F, Plana M, Iruarrizaga E, Temam S, Even C, Ruiz EP, Bert M, Karamouza E, Thariat J, Kazmierska J, Psyrri A, Mesia R, Tao Y

BACKGROUND: Postoperative cisplatin and radiotherapy is the standard of care for high-risk resected locally advanced squamous cell carcinoma of the head and neck (LA-SCCHN). The NIVOPOST-OP trial aimed to assess the efficacy and safety of programmed death 1 blockade by nivolumab added to cisplatin and radiotherapy in this setting. METHODS: This open-label, phase 3 trial evaluated adding nivolumab to cisplatin and radiotherapy after surgery for LA-SCCHN with high-risk pathological features. The…



Quizartinib for Newly Diagnosed FLT3-Internal Tandem Duplication-Negative AML: The Randomized, Double-Blind, Placebo-Controlled, Phase II QUIWI Study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Montesinos P, Rodríguez-Veiga R, Bergua JM, Algarra Algarra JL, Botella C, Rodríguez-Arbolí E, Bernal T, Tormo M, Calbacho M, Salamero O, Serrano J, Noriega V, López-López JA, Vives S, López-Lorenzo JL, Colorado M, Vidriales MB, García Boyero R, Olave MT, Herrera Puente P, Arce O, Barrios M, Jose Sayas M, Polo M, Gómez-Roncero MI, Barragán E, Ayala R, Chillón C, Calasanz MJ, Paiva B, Boluda B, Casas-Avilés I, Lloret-Madrid P, Sánchez MJ, Rodríguez-Medina C, Cuevas L, Raposo-Puglia JÁ, Mateos MC, Olivares M, Martínez-Chamorro C, Alonso N, Suárez S, Sánchez-Vadillo I, Solé Rodríguez M, González BJ, Martínez-Francés A, Cuello R, Fernández A, Martínez-Cuadrón D, Labrador J

PURPOSE: Quizartinib, an oral, selective, second-generation, type-II FMS-like tyrosine kinase 3 (FLT3) inhibitor with high binding affinity to internal tandem duplication (ITD) and wild-type (WT) FLT3, has shown early clinical activity as monotherapy in patients with relapsed/refractory FLT3-ITD-negative AML. The phase III QuANTUM-First trial showed that quizartinib significantly prolonged survival versus placebo when added to standard chemotherapy, followed by single-agent maintenance, in…



Hepatic Encephalopathy and MELD-Na Predict Treatment Benefit in Autoimmune Hepatitis-related Decompensated Cirrhosis.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Arvaniti P, Rodríguez-Tajes S, Padilla M, Olivas I, Mauro E, El Maimouni C, Lytvyak E, Verhelst X, Engel B, Taubert R, Lorente-Pérez S, Conde I, Riveiro-Barciela M, Ruiz-Cobo JC, Álvarez-Navascués C, Salcedo M, Gómez J, Janik MK, Mateos B, Efe C, Granito A, Dajti E, Azzaroli F, Horta D, Vila C, Castello I, Pérez-Medrano I, Arencibia A, Gerussi A, Bruns T, Colaprieto F, Lleo A, Van den Ende N, Verbeek J, Díaz-González Á, Morillas RM, Torner-Simó M, Bernal V, Fernández EM, Gevers TJG, Terziroli Beretta-Piccoli B, Gómez E, Cuenca P, de Boer YS, Kerkar N, Assis DN, Liberal R, Drenth JPH, Tana MM, Sebode M, Schregel I, Schramm C, Lohse AW, Montano-Loza AJ, Zachou K, Villamil A, Dalekos GN, Londoño MC

BACKGROUND & AIMS: Management of patients with autoimmune hepatitis (AIH)-related decompensated cirrhosis is challenging because of the risk of treatment-related complications and lack of clinical recommendations. We investigated the predictive factors for treatment benefit in AIH-related decompensated cirrhosis at diagnosis and developed an algorithm to guide treatment decisions in clinical practice. METHODS: This retrospective, international, multicenter study included 232 patients with…



Muscular and plasma markers for early identification of frailty and sarcopenia states in people with HIV.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Hernández-Sánchez D, Satorra P, Martínez A, Puig J, González S, Rupert A, Monté-Rubio G, Echeverria P, Bonjoch A, Ferrer-Arbaizar J, Tebe C, Puig J, Sereti I, Negredo E

BACKGROUND: Healthcare needs of older people with HIV (PWH) are changing given the higher incidence and earlier onset of age-related conditions compared to people without HIV (PWoH). This emphasizes a need for novel prognostic markers that allow identification of earlier stages of functional deterioration and prevent its advancement. METHODS: With this aim, we compared muscular imaging markers (whole-body MRI) and plasma biomarkers (irisin, myostatin, and coenzyme Q10) between PWH ( n = 50) and…



Risk Factors for Oropharyngeal Dysphagia in Older Adults-Evidence from Consorci Sanitari Del Maresme and Mataró University Hospital, Catalonia, Spain

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Guidotti L, Castañeda-Maldonado JI, Santiago M, Clavé P, Ortega O

Oropharyngeal dysphagia (OD) is a highly prevalent geriatric syndrome that remains underdiagnosed and undertreated, often resulting in severe nutritional and respiratory complications with poor clinical outcomes. Its risk factors are still not well defined, representing a critical gap in efforts to understand its pathophysiology, prevent the condition and reduce its associated complications. To analyze data from comprehensive studies conducted in a single-center setting to ascertain the major…



European Expert Recommendations on Teclistamab Management for Relapsed or Refractory Multiple Myeloma.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rodríguez-Otero P, Moreau P, Mateos MV, Krauth MT, Rasche L, Kastritis E, Oriol A, Zamagni E, Albrecht C, Rubio-Azpeitia E, van de Donk NWCJ

The global incidence of multiple myeloma (MM) continues to rise. While survival rates for newly diagnosed patients have improved substantially with the introduction of novel therapies, outcomes remain poor for those with triple-class-exposed (TCE) relapsed/refractory MM (RRMM). Recent therapeutic innovations, including chimeric antigen receptor T-cell therapy, antibody-drug conjugates, and bispecific antibodies, offer new effective options for this challenging population. Teclistamab, the first…



Lebrikizumab is efficacious in adults and adolescents with moderate-to-severe atopic dermatitis regardless of atopic comorbidities.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Sher ER, Golant A, de Bruin-Weller M, Carrascosa JM, Mehta V, Bieber T, Dawson Z, Atwater AR, Zhong J, Rodriguez Calleja L, Boguniewicz M

BACKGROUND: Atopic comorbidities are common in patients with atopic dermatitis (AD) and increase disease burden. Lebrikizumab monotherapy demonstrated efficacy and safety through 52 weeks in patients with moderate-to-severe AD in phase 3 trials (ADvocate1 [NCT04146363]; ADvocate2 [NCT04178967]). OBJECTIVE: To evaluate the impact of atopic comorbidities on lebrikizumab efficacy and response maintenance in patients with AD using pooled data from ADvocate1 and ADvocate2. METHODS: At the end of the…



Proactive Management and Treatment of Aortic Stenosis: An International Expert Perspective.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Cook CM, Pibarot P, Tarantini G, Généreux P, Delgado V, Hayashida K, Parma R, Kaneko T, Rudolph TK, Cavalcante JL, Wood DA, Bax JJ, Pilgrim T, Saia F, Vemulapalli S, Pellikka PA, Iung B, Guibone K, Dweck MR, Eltchaninoff H, Ailawadi G, Lam SC, Poon K, Unbehaun A, Schwartz A, Joner M, Prendergast B, Mack M, Hahn RT, Windecker S, Leon MB, Lindman BR

The 2025 European Society of Cardiology/European Association for Cardio-Thoracic Surgery guidelines mark a pivotal change, challenging the paradigm of symptom-driven watchful waiting, and supporting earlier treatment in many patients with asymptomatic severe aortic stenosis. Building on this foundation, this international expert perspective advocates a comprehensive, proactive management strategy and offers clinicians a contemporary operational framework for managing severe aortic stenosis. Key…



Endotrophin as a biomarker and mediator in cardiovascular-kidney-metabolic syndrome: current insights and remaining questions.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Genovese F, Karsdal M, Devos H, Bager C, Nuñez J, Bayes-Genis A

Endotrophin, a biologically active fragment derived from the a3 chain of collagen type VI, has emerged as both a risk biomarker and a potential pathogenic factor in cardiovascular-kidney-metabolic (CKM) syndrome. Over the past decade, research has shed light on its role in various noncommunicable diseases, emphasizing its signaling properties and diagnostic potential. Despite these advances, significant gaps remain in our understanding of how endotrophin contributes to CKM pathophysiology and…



The impact of thyroid disorders on the gut microbiome: emerging mechanisms and clinical relevance

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Silva IB, Puig-Domingo M

The thyroid-gut axis represents a dynamic interaction between the intestinal microbiota and thyroid function, with growing evidence linking gut dysbiosis to thyroid diseases. The gut microbiome, comprising over 100 trillion microorganisms, influences immune modulation, iodine metabolism, and thyroid hormone regulation. Short-chain fatty acids, produced by beneficial gut bacteria, support immune homeostasis and thyroid function, while pathogenic bacteria and lipopolysaccharides trigger…



Performance of large language models in addressing patient queries on colorectal cancer screening in different languages: An international study across 28 countries.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
M M, A P, S G, T V, Lhs L, S B, P P, M M, T Z, H U, Ejt A, D B, H D, T D, A G, T K, S L, B L, H M, R N, Y O, A R, A T, I M

BACKGROUND: Colorectal cancer (CRC) screening reduces incidence and mortality, yet patient adherence remains suboptimal. Large language models may improve participation by addressing patient questions in native languages, but their multilingual performance has not been systematically assessed. METHODS: From April to June 2025, we conducted a cross-continental study involving 28 countries and 23 languages. A standardized set of 15 CRC screening-related questions was translated into each language…



EEG biomarkers for a precision-medicine approach to noninvasive brain stimulation for major depressive disorder.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Romero-Marín R, Cappon D, Solana-Sánchez J, Bartrés-Faz D, Pascual-Leone Á, Cattaneo G

Major depressive disorder (MDD) is a prevalent and disabling condition with high rates of treatment resistance. Non-invasive brain stimulation (NIBS), including transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (tES), has emerged as a promising option for individuals unresponsive to pharmacotherapy. However, many patients still fail to achieve meaningful improvement, underscoring the need for reliable biomarkers of treatment response. Electroencephalography (EEG)…



Effect of Onset-to-Admission Time and Care Bundle Achievement on Functional Outcomes in Patients With ICH: A Population-Based Study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Lambea-Gil Á, Marti-Fabregas J, Cardona P, Rodriguez-Luna D, Millán M, Amaro S, Prats-Sanchez L, Silva Y, Seró L, Rodriguez-Campello A, Cánovas D, Martinez-Domeño A, Guasch-Jiménez M, Ezcurra-Díaz G, Carcel-Marquez J, Fernandez-Cadenas I, Pérez De La Ossa N, Abilleira S, Salvat-Plana M, Fagundez O, Camps-Renom P, Ramos-Pachón A

BACKGROUND AND OBJECTIVES: Intracerebral hemorrhage (ICH) remains a leading cause of morbidity and mortality, with limited effective treatments. Early implementation of a care bundle protocol (CBP) within 6 hours of symptom onset has been shown to improve functional outcomes, although its effect beyond this time frame remains unclear. We assessed the impact of onset-to-admission (OTA) time and CBP achievement on functional outcome and mortality in patients with acute spontaneous ICH. METHODS:…



Dynamic Changes in Right Ventricular-Pulmonary Arterial Coupling During Acute Heart Failure Hospitalization: Prognostic Implications.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Anastasiou V, Stavropoulou E, Peteinidou E, Nikolaidou A, Daios S, Fardoulis E, Karamitsos T, Giannakoulas G, Naka K?, Delgado V, Ziakas A, Kamperidis V

Right ventricular (RV) - pulmonary arterial (PA) uncoupling is an important predictor of outcomes in heart failure (HF), yet it may change substantially during hospitalization for acute HF. This study sought to investigate the dynamic changes in RV-PA uncoupling during acute HF hospitalization and their prognostic significance. Tricuspid annular plane systolic excursion to pulmonary artery systolic pressure (TAPSE/PASP) ratio was measured in consecutive hospitalized acute HF patients using…



CTBN-PH: A continuous-time Bayesian network for individualised diagnostic risk prediction.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Guillamet GH, Seguí FL, Vidal-Alaball J, López B

Continuous-time Bayesian networks (CTBNs) are powerful tools for modelling and predicting complex disease trajectories in continuous-time scenarios. However, their application is often limited by a lack of individualisation in the results, if the covariates significantly influence a patient's diagnostic transitions. To address these challenges, we introduce the CTBN-PH model, which integrates CTBN models with Cox proportional hazards (Cox-PH) models. The proposed model combines the dynamic…



A Novel Heterologous Prime-boost Strategy Using RUTI Vaccine to Improve the Bacillus Calmette-Guérin Response in Non-muscle-invasive Bladder Cancer Patients: Phase 1 RUTIVAC-1 Trial.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Buisan O, Servian P, Pedreño-Lopez S, Pagès J, Urrea V, Martínez R, Garcia E, Cardona PJ, Vilaplana C, Amat M, Areal J, Bellmunt J, Clotet B, Cabrera C

Intravesical bacillus Calmette-Guérin (BCG) is the standard treatment for high-risk non-muscle-invasive bladder cancer (NMIBC); however, recurrence and progression remain major challenges. To explore a heterologous prime-boost strategy, we conducted the RUTIVAC-1 trial (NCT03191578) to evaluate RUTI, a nonlive vaccine, derived from Mycobacterium tuberculosis, as a systemic primer prior to intravesical BCG in high-risk NMIBC patients. The immunogenicity, safety, and preliminary efficacy of RUTI…



New molecular markers of response to medical therapy in acromegaly.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Raventós A, Gil J, Marques-Pamies M, de Pedro-Campos P, Puente de la Vega C, Picó A, Lamas C, Delgado E, Menéndez E, Serra G, Bernabéu I, Villar R, Ferri J, Mariaca K, Martínez R, Marazuela M, Araujo-Castro M, Biagetti B, Jordà M, Valassi E, Puig-Domingo M

The management of pituitary neuroendocrine tumors (PitNETs) is shifting toward a personalized medicine approach, supported by the identification of biomarkers that can guide individualized surgical and medical strategies. In acromegaly, medical therapy with somatostatin receptor ligands (SRLs), dopamine agonists, and GH receptor antagonists represent the cornerstone of treatment in patients with persistent disease after surgery or when surgery cannot be performed. However, therapeutic outcomes…



Inflammatory and Immune Effects of Pollution: Comparison Between Patients With Asthma and Healthy Individuals.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Soler-Segovia D, Romero-Mesones C, Espejo D, Pilia F, Ojanguren I, Martinez-Rivera C, Muñoz X, Cruz MJJ

BACKGROUND: The objective of this study was to assess inflammatory and immune responses in patients with asthma and healthy controls exposed to a polluted and a nonpolluted environment over a short period. MATERIAL AND METHODS: We performed a randomized crossover study in patients with asthma (n=20) and in healthy controls (n=15). Participants were exposed for 2 hours to a polluted environment and, after 14 days, to a nonpolluted environment. Pollution levels were assessed at each exposure.…



Cost Analysis of Technetium-99m versus Indocyanine Green for Sentinel Lymph Node Biopsy in Breast Cancer.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Boyanova IMB, Aulina LB, Iglésia M, López-Cano D, Serra-Serra C, Ruiz-Edo N, Salcedo-Pujantell M, Ibañéz JFJ, Gordo SL

BACKGROUND: Sentinel lymph node biopsy (SLNB) using Technetium-99 (Tc-99) is the standard technique for axillary staging in breast cancer. However, it has logistic issues, especially in hospitals without a nuclear medicine department (NMD). As the sensitivity and specificity of indocyanine green (ICG) are comparable to those of Tc-99, the aim of this study was to perform a cost-benefit analysis of the 2 methods. MATERIALS AND METHODS: A prospective observational cohort of patients undergoing…



Second edition of the "do not do" recommendations from the Spanish Society of Endocrinology and Nutrition (SEEN).

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Díez JJ, Gargallo Fernández M, Gimeno Orna JA, González Arnaiz E, Huguet Moreno I, Martínez Couselo S, Miguélez González M, Ocón MJ, Pérez López G, Pita Gutiérrez F, Reverter Calatayud JL, Tejera Pérez C, Urgell Rull E, Fernández A

Low-value clinical practices - defined as diagnostic or therapeutic interventions that provide limited clinical benefit and may be associated with unnecessary risks or costs - remain common in endocrinology and nutrition. The Spanish Society of Endocrinology and Nutrition (SEEN) presents this second edition as an updated set of recommendations on "what not to do" in clinical practice, developed by its sections and working groups. The methodological process included the selection of…



Disposition and effects of alpha-pyrrolidinoisohexanophenone (a-PHiP) in comparison with cocaine: an observational study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
De la Rosa G, Iacobone G, Papaseit E, Hladun O, Poyatos L, Caicedo DA, Argote MC, Martín S, Ventura M, Di Giorgi A, Graziano S, Pichini S, Marchei E, Farré M, Pérez-Mañá C

INTRODUCTION: Alpha-pyrrolidinoisohexanophenone (a-PHiP) is a synthetic cathinone structurally related to alpha-pyrrolidinopentiophenone (a-PVP) and other pyrrolidinophenones, acting as a potent monoamine transporter inhibitor. Despite its raising prevalence on the recreational drug market, limited data exist about its human pharmacology. This study aimed to assess its concentrations in different matrices and characterize its acute effects in humans in comparison with cocaine when administered…



Validation of prognostic scores in patients with HIV-related diffuse large B-cell lymphoma: The value of peripheral blood parameters-A study from the Spanish Lymphoma Group GELTAMO.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Huguet M, Morgades M, Rivas-Delgado A, Bastos-Oreiro M, Córdoba R, Salar A, de la Cruz-Vicente F, Alcoceba M, Ferrer-Lores B, Jiménez-Ubieto A, Gutiérrez A, Infante M, Huerga S, Abrisqueta P, Cruz D, Montalbán C, Muntañola A, Villambrosia SG, Ribera JM, Navarro JT




"Measurement of skin thickness using ultra-high frequency ultrasound. A validated method with cut-off values to assess upper limb lymphedema.".

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Malagón P, Carrasco C, Del Río M, Blasi M, Xarrié J, Higueras C

INTRODUCTION: Evaluation of the severity and progression of lymphedema is challenging and there is no universal, simple and accurate established method. We propose the use of ultra-high frequency ultrasound (UHFUS) to measure skin thickness to assess lymphedema. METHODS: Skin thickness was measured twice at 8 points in the upper limbs of 40 women using UHFUS (20 with unilateral lymphedema secondary to breast cancer and 20 healthy volunteers). Measurements were statistically compared with limb…



Diet and Clinical Outcomes in a Heart Failure Population.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Joseph P, Dehghan M, Ezekowitz JA, Miller V, Lanas F, AlHabib KF, Gomez-Mesa JE, ElSayed A, Lopez-Jaramillo P, Avezum A Jr, Bayes-Genis A, Ertl G, Lund LH, Karaye K, Maggioni A, Diaz ML, Balasubramanian K, Grinvalds A, Roy A, Pogosova N, Temizhan A, Leong D, McCready T, Yusuf S

BACKGROUND: There are limited data to inform dietary recommendations in persons with heart failure (HF). OBJECTIVES: The aim of this study was to examine associations between consumption levels of 11 common foods, and a healthy diet pattern, with clinical outcomes in a HF population. METHODS: This analysis was a substudy of 3,798 participants from 25 countries enrolled in the multinational G-CHF (Global Congestive Heart Failure) registry with dietary data collected through food frequency…



From Evidence to Outcomes: The Evolving Continuum of Cardiovascular Care

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Andrea R, Izquierdo-Ribas M, Sanz E, García-García C, Sambola A, Sionis A, Sánchez-Salado JC, Pastor P, Azeli Y, Pineda GB, Martínez-Membrive MJ, Soriano-Colomé T, Sans-Roselló J, Moreno-Monterde E, Roca-Guerrero C, Ortiz-Pérez J, López-Sobrino T, de Diego O, Freixa X, Loma-Osorio P




Defining Noninvasive Criteria for Indicating Drug Therapy in Metabolic Dysfunction-associated Steatotic Liver Disease in Clinical Practice.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Olveira A, Crespo J, Ibañez-Samaniego L, Gallego-Durán R, Calleja JL, Aller R, Soria A, Gómez-Camarero J, Martín-Mateos R, Benlloch S, Pericàs JM, Morillas RM, Bernal-Monterde V, Diago M, Turnes J, Poca M, Lo Iacono O, Maya-Miles D, Escudero D, Andrade RJ, Rosales JM, Jorquera F, Fernández-Rodríguez C, Hernández-Guerra M, Romero-Gómez M, Ampuero J

BACKGROUND & AIMS: Resmetirom is the first Food and Drug Administration-approved drug for metabolic dysfunction-associated liver disease (MASLD) in F2 and F3 patients with steatohepatitis. Noninvasive criteria have been proposed for initiating treatment; however, these have not been validated in clinical practice. We validated the proposed criteria and established new guidelines for initiating resmetirom treatment in clinical practice. METHODS: This was a cross-sectional study of 1281 MASLD…



Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rial MJ, Betancor D, Cañas JA, Olaguibel JM, Rodrigo-Muñoz JM, Alvarez-Puebla MJ, Arismendi E, Barroso B, Bobolea I, Cárdaba B, Cruz MJ, Curto E, Del Pozo V, Domínguez-Ortega J, Garcia de la Fuente A, González-Barcala FJ, Luna-Porta JA, Martínez-Rivera C, Mullol J, Muñoz X, Picado C, Plaza V, Quirce S, Soto-Retes L, Valverde-Monge M, Sastre J




A scoring system to predict life-threatening thromboischemic events in patients with acute promyelocytic leukemia: the PETHEMA/PALG study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rodríguez-Veiga R, Gil C, Sobas M, Torres-Miñana L, Botella C, De la Serna J, Bernal T, Salamero O, Otero C, Navarro-Vicente I, De Miguel C, Garrido A, Vives S, Bergua J, Pérez-Encinas M, Algarra L, González-Campos J, Gómez MDMC, Prates MV, Benavente C, Tormo M, Cervera M, Fazio P, Amutio ME, García R, Pomares H, Vidriales B, Serrano J, Amigo ML, Rubio V, Almela Á, Barrios M, Sossa-Melo CL, Paluszewska M, Novo A, Gromek T, Rodríguez-Macías G, Oleksiuk J, Lloret-Madrid P, Montesinos P

Acute promyelocytic leukemia (APL) is a highly curable leukemia characterized by life-threatening coagulopathy leading to hemorrhagic and thrombo-ischemic events. We analyzed the incidence, outcomes and risk-factors of thromboischemic events in a large series of 1210 patients with newly diagnosed APL reported to the PETHEMA registry. Therapy consisted on ATRA and chemotherapy (AIDA-based). Median age of patients was 46 years (range 2-90 years). Fifty-eight patients (5%) did not start AIDA…



Cardiac Biomarkers, Intensive Lifestyle Intervention, and Heart Failure Subtypes in Diabetes: Look AHEAD Cardiac Biomarker Ancillary Study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Chunawala Z, Patel KV, Garcia KR, Segar MW, Verma S, Bayes-Genis A, Pop-Busui R, Bhatt DL, Januzzi JL Jr, Butler J, Lam CSP, Bertoni AG, Espeland M, Pandey A

BACKGROUND: N-terminal pro-B-type natriuretic peptide (NT-proBNP) identifies elevated risk for developing heart failure (HF) in type 2 diabetes (T2D). Whether risk of HF subtypes associated with NT-proBNP is modifiable with an intensive lifestyle intervention (ILI) targeting weight loss is unknown. OBJECTIVES: This study aims to evaluate the association of baseline and longitudinal changes in NT-proBNP with risk of HF subtypes in T2D. In addition, we assessed whether NT-proBNP modified the…



Growth Hormone Assay-Adjusted Standardization Reveals Distinct Clinical Phenotypes in Acromegaly.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Biagetti B, Marques P, Ferrer R, Cardoso LM, Moreno EV, Fajardo-Montañana C, Gonzalez-Fernandez L, Pérez Pena MM, García-Centeno R, Lozano-Aida C, Novoa-Testa I, Pascual-Corrales E, Sánchón R, Guerrero-Pérez F, Rodríguez RO, Jiménez BR, Ollero García MD, Echarri AI, Simó-Servat A, Moure Rodríguez MD, Calatayud M, Villar-Taibo R, Tenorio-Jimenéz C, Novo-Rodríguez C, Molero IG, Iglesias P, Blanco C, Vidal-Ostos De Lara F, Aulinas A, Asla Roca Q, Paja M, Abellán Galiana P, Cordido F, Menéndez Torre E, Cámara R, Sarria-Estrada S, Aznar Rodríguez S, Lamas C, Alvarez-Escola C, Bernabéu I, Hanzu F, Marazuela M, Puig-Domingo M, Araujo-Castro M

OBJECTIVE: To identify distinct clinical phenotypes in acromegaly based on growth hormone (GH) assay standardization and unsupervised machine learning. METHODS: This was a multicenter cross-sectional analysis of 416 patients diagnosed with acromegaly from 2010 onward. Patients were stratified according to baseline serum GH levels standardized to the assay-specific upper limit of normal (GHxULN) using a binary classification (GH-B: <1.0×ULN vs =1.0×ULN) and a four-tier classification (GH-4:…



Standardized Definition of Progression Independent of Relapse Activity (PIRA) in Relapsing-Remitting Multiple Sclerosis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Müller J, Sharmin S, Lorscheider J, Ozakbas S, Karabudak R, Horakova D, Weinstock-Guttman B, Shaygannejad V, Etemadifar M, Alroughani R, Patti F, Eichau S, Prat A, Lugaresi A, Tomassini V, Kermode AG, Amato MP, Turkoglu R, Altintas A, Buzzard K, Soysal A, van der Walt A, Butzkueven H, Blanco Y, Gerlach O, Khoury SJ, Barnett M, John N, Lechner-Scott J, Foschi M, Surcinelli A, van Pesch V, Prevost J, Sa MJ, Maimone D, D'hooghe M, Hughes S, Hodgkinson S, McGuigan C, Cartechini E, Taylor B, Spitaleri D, Slee M, McCombe P, Yamout B, Benkert P, Kuhle J, Kappos L, Roos I, Kalincik T, Havrdova EK, Girard M, Duquette P, Fabis-Pedrini M, Carroll WM, Skibina O, Gouider R, Mrabet S, Ramo-Tello C, Solaro C, Habek M, Van Wijmeersch B, Ampapa R, Macdonell R, Oreja-Guevara C, de Gans K, Laureys G, Oh J, Garber J, Gray O, Agüera-Morales E, Sanchez-Menoyo JL, Castillo-Triviño T, Grigoriadis N, Petersen T, Hardy TA, Vucic S, Reddel S, Ramanathan S, Al-Asmi A, Simu M, Baghbanian SM, Poehlau D, Al-Harbi T, Rojas JI, Deri N, Lalive P, Cambron M, Csepany T, Shuey N, Willekens B, Shaw C, Decoo D, Massey J, Yaldizli Ö, Derfuss T, Granziera C

Importance Progression independent of relapse activity (PIRA) is a significant contributor to long-term disability accumulation in relapsing-remitting multiple sclerosis (MS). Prior studies have used varying PIRA definitions, hampering the comparability of study results. Objective To compare various definitions of PIRA. Design, Setting, and Participants This cohort study involved a retrospective analysis of prospectively collected data from the MSBase registry from July 2004 to July 2023. The…



Implementation of cervical ultrasound and related techniques in endocrinology and nutrition services in Spain. ECOSEEN 2025 study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Reverter JL, Díaz Soto G, Martin T, Gargallo M, Sambo M, Argüelles I

INTRODUCTION: Before 2014, few Endocrinology and Nutrition Departments nationwide routinely used cervical ultrasound. Following the training activities promoted by the Thyroid Pathology Imaging Group, it is important to evaluate the current level of implementation of ultrasound and ultrasound-guided techniques in clinical practice. MATERIAL AND METHODS: A structured, self-administered survey was designed and sent electronically to hospitals throughout the country. RESULTS: Responses were…



Socioeconomic Deprivation in Ischemic Stroke Treated With Endovascular Thrombectomy: Not All Recoveries Are Equal.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Montalvo C, Garcia-Tornel A, Olive-Gadea M, Rodrigo-Gisbert M, Requena M, Rizzo F, Rodriguez-Luna D, Rodriguez-Villatoro N, Pagola J, Simonetti R, Perez de la Ossa N, Camps-Renom P, Canovas D, Flores A, Rodriguez-Campello A, Silva Y, Urra X, Purroy F, Bustamante A, Salvat-Plana M, Cardona P, Molina C, Rubiera M, Ribo M

BACKGROUND: The influence of socioeconomic deprivation on outcomes in ischemic stroke patients treated with thrombectomy remains unclear. METHODS: We analyzed 6219 patients with ischemic stroke treated with thrombectomy between 2016 and 2023 in Catalonia, Spain. Socioeconomic deprivation was defined at the health care service area level (n=378) as the proportion of inhabitants with an annual income below $21 000. The adjusted absolute difference in the proportion of patients achieving good…



Subcutaneous blinatumomab in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia: post-hoc safety and activity analysis from a multicentre, single-arm, phase 1/2 trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Jabbour E, Lussana F, Martínez-Sánchez P, Torrent A, Rifón JJ, Agrawal V, Tormo M, Cassaday RD, Cluzeau T, Huguet F, Papayannidis C, Hernández-Rivas JM, Rijneveld A, Fleming S, Vucinic V, Böll B, Ikezoe T, Abdul-Hay M, Savoie ML, Schuh AC, Berthon C, Schwartz S, Chiaretti S, Yuda J, Miyazaki T, González-Campos J, Chen Y, Wong H, Choudhry J, Zugmaier G, Guest E, Gordon P, Kantarjian H

Background Two doses of subcutaneous blinatumomab in patients with relapsed or refractory B-cell acute lymphoblastic leukaemia were identified as preliminary recommended phase 2 doses, based on the dose-escalation phase of this multicentre single-arm, phase 1/2 trial. Here, we aim to further study the safety, activity, and pharmacokinetics of these doses in all participants who have received them, including those treated in the completed phase 1b expansion part of the study. Methods We did a…



Ruxolitinib in acute and chronic graft-versus-host disease: real life long-term experience in a multi-center study for adult and pediatric patients, on behalf of the GETH-TC.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Escamilla-Gómez V, García Gutiérrez V, Alcalde-Mellado P, Astibia-Mahillo B, Chinea-Rodriguez A, López-Corral L, Acera-Gómez M, Torres Ochando MK, Borrero Borrego A, González Pinedo L, Zudaire Ripa T, González Vicent M, Benzaquén A, Izquierdo Garcia I, Asensi Cantó P, Montoro J, Martín-Domínguez FM, Orti G, Valcárcel D, Benitez-Carabante MI, Diaz-de-Heredia C, Cañamero E, Ferrá C, García-Cadenas I, Redondo S, Sisinni L, Perez-Martínez A, Mussetti A, Garcia-Mañó L, Palomo-Moraleda MDP, González-Sierra PA, Jurado M, Perez-Simon JA

Ruxolitinib has been approved for the treatment of adults and pediatric patients =12 years with steroid refractory graft-versus-host disease (GvHD). However, real-life studies are needed to confirm the results of clinical trials and further assess its efficacy in special populations. We performed a descriptive, retrospective, multi-center study of 352 adults and 42 pediatric patients treated with ruxolitinib for steroid-refractory acute or chronic GvHD. Among 119 and 233 adult patients with…



Pituitary Apoplexy: Comorbidities, Management, and Outcomes-A Spanish Observational Multicenter Study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Biagetti B, Cordero Asanza E, Pérez-López C, Araujo-Castro M, Camara R, Guerrero-Pérez F, Vicente A, Lamas C, Serra G, Echarri AI, Ollero MD, González Molero I, Villar-Taibo R, Moure Rodríguez MD, García-Feijoo P, Berrocal VR, Sánchez Ramirez MN, Gutiéerrez Hurtado A, Capristan-Díaz V, Simó-Servat A, Gallach M, Safont Perez E, González Rosa V, Civantos S, Asensio-Wandosell D, Martinez-Saez E, Menéndez Torre E, Aulinas A, Iglesias P, Diez JJ, Bernabéu I, Álvarez-Escolá C, Puig-Domingo M

BACKGROUND: Pituitary apoplexy (PA) is the paradigm of endocrine and neurosurgical emergency. OBJECTIVE: To evaluate the comorbidities, risk factors, clinical presentation, pituitary apoplexy score (PAS), and the outcomes of surgical vs conservative management of PA in Spain. METHODS: Spanish multicenter, observational study of 301 patients with acute PA. Statistical analyses compared risk factors, clinical presentation, and outcomes between surgical and conservative treatment groups, adjusting…



A single-arm phase IIIb study of 8-week glecaprevir/pibrentasvir treatment in adults with acute hepatitis C.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Llibre JM, Boesecke C, Moon J, Lank PM, Miller MG, Fredrick LM, Welhaven A, Semizarov D, Marcinak J, Gentile I, Reiberger T, Puoti M

BACKGROUND & AIMS: With over 1 million new HCV infections in 2022, treating acute HCV is essential to achieve WHO's HCV elimination goal. Although guidelines recommend prompt treatment, no direct-acting antiviral is approved for acute HCV outside of the US, leading to loss of patients to care while waiting for chronicity, and increased onward transmission. This single-arm, phase IIIb study evaluated the efficacy and safety of an 8-week glecaprevir/pibrentasvir regimen in treatment…



Intravenous Ferric Carboxymaltose in Ischemic Versus Non-Ischemic Heart Failure and Iron Deficiency: Insights From FAIR-HF2.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Khan MS, Butler J, Karakas M, Placzek M, Hasenfuß G, Talha KM, Bayes-Genis A, Coats AJ, Böhm M, Rosano G, Savarese G, Anker MS, Ponikowski P, Friede T, Anker SD

BACKGROUND: Previous studies have suggested that patients with ischemic etiology of heart failure (HF) and iron deficiency may derive greater benefits with intravenous ferric carboxymaltose (FCM). We aim to assess the effects of FCM versus placebo in patients with ischemic versus non-ischemic etiology of HF. METHODS AND RESULTS: The FAIR-HF2 trial included 1105 patients with HF, with a left-ventricular ejection fraction =45%, and concomitant iron deficiency. Patients were randomized 1:1 to…



The use of Left Ventricular Ejection Fraction in the Diagnosis and Management of Heart Failure. A Clinical Consensus Statement of the Heart Failure Association (HFA) of the ESC, the Heart Failure Society of America (HFSA), and the Japanese Heart Failure Society (JHFS).

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rosano GMC, Teerlink JR, Kinugawa K, Bayes-Genis A, Chioncel O, Fang J, Greenberg B, Ibrahim NE, Imamura T, Inomata T, Kuwahara K, Moura B, Onwuanyi A, Sato N, Savarese G, Sakata Y, Sweitzer N, Wilcox J, Yamamoto K, Metra M, Coats AJS

This clinical consensus statement revisits the role of left ventricular ejection fraction (LVEF) as a measurement of cardiac function, a prognostic marker and a major criterion to classify patients with heart failure, and gives new advice for clinical practice. Heart failure is traditionally classified on the basis of LVEF thresholds and this has major implications for treatment recommendations. However, the reproducibility of LVEF measurement is poor and its prognostic and diagnostic value…



The role of genetic testing in accurate diagnosis of X-linked sideroblastic anemia: novel ALAS2 mutations and the impact of X-chromosome inactivation

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Jové-Solavera D, Rámila M, Ferrer-Cortés X, Olivella M, Venturi V, Morado M, Hernández-Rodríguez I, Khan A, Pérez-Montero S, Tornador C, Germing U, Gattermann N, Sanchez M

X-linked sideroblastic anemia (XLSA) is a hereditary disorder affecting heme biosynthesis, caused by mutations in the ALAS2 gene, which encodes the erythroid-specific enzyme 5-aminolevulinate synthase. This enzyme, which requires pyridoxal 5'-phosphate (PLP) as a cofactor, catalyzes the first and rate-limiting step of heme synthesis in erythroid cells. XLSA is characterized by hypochromic microcytic anemia and ring sideroblasts in bone marrow, with most patients showing variable degrees of…



Resilience and emergence of pneumococcal serotypes and lineages in adults post-PCV13 in Spain: A multicentre study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Calvo-Silveria S, González-Díaz A, Marimón JM, Cercenado E, Quesada MD, Casabella A, Larrosa N, Berbel D, Alonso M, Bernat-Sole M, Saiz-Escobedo L, Yuste J, Martí S, Càmara J, Ardanuy C

BACKGROUND: Streptococcus pneumoniae causes invasive pneumococcal disease (IPD) in adults. The introduction of pneumococcal conjugate vaccines (PCVs) has reduced vaccine serotypes but has also led to the rise of non-vaccine serotypes. The aim of this study was to analyse pneumococcal lineages and their association with recent changes in IPD among adults in Spain. METHODS: Data from adult IPD cases (=18 years) were collected from six Spanish hospitals in 2019-2021. Strains were serotyped, tested…



A phase 2 open-label study of cemiplimab in patients with advanced cutaneous squamous cell carcinoma (EMPOWER-CSCC-1): Final long-term analysis of groups 1, 2, and 3, and primary analysis of fixed-dose treatment group 6.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Hughes BGM, Guminski A, Bowyer S, Migden MR, Schmults CD, Khushalani NI, Chang ALS, Grob JJ, Lewis KD, Ansstas G, Day F, Ladwa R, Stein BN, Muñoz Couselo E, Meier F, Hauschild A, Schadendorf D, Basset-Seguin N, Modi B, Dalac-Rat S, Dunn LA, Flatz L, Mortier L, Guégan S, Heinzerling LM, Mehnert JM, Trabelsi S, Soria-Rivas A, Stratigos AJ, Ulrich C, Wong DJ, Beylot-Barry M, Bossi P, Bugés Sánchez C, Chandra S, Robert C, Russell JS, Silk AW, Booth J, Yoo SY, Seebach F, Lowy I, Fury MG, Rischin D

BACKGROUND: In the phase 2 EMPOWER-CSCC-1 study (NCT02760498), cemiplimab demonstrated antitumor activity against metastatic cutaneous squamous cell carcinoma (mCSCC) and locally advanced cutaneous squamous cell carcinoma (laCSCC). OBJECTIVES: To report final analysis of weight-based cemiplimab in mCSCC and laCSCC (groups 1 and 2), fixed-dose cemiplimab in mCSCC (group 3), and primary analysis of fixed-dose cemiplimab in mCSCC/laCSCC (group 6). METHODS: Patients received cemiplimab (3 mg/kg…



Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Montez de Sousa IR, Bonthuis M, Kramer A, Ordoñez FA, de la Cerda Ojeda F, Rydell H, Helve J, Groothoff JW, Hommel K, Buchwinkler L, Segelmark M, Arici M, Palsson R, Bell S, Trujillo-Alemán S, Bakkaloglu SA, Sørensen SS, Vila A, Ortiz A, Stel VS, Jager KJ

BACKGROUND: Young adults starting kidney replacement therapy (KRT) during childhood and reaching their 18th birthday (i.e. adult survivors of childhood KRT) form a challenging population of interest to nephrologists treating adults, as during this period there will be a transition to adult renal centres. Nonetheless, few studies have focused on the epidemiology of KRT in this group. We aimed to provide an update on these patients' characteristics, treatment history, and graft and patient…



Glasdegib in combination with temozolomide and radiotherapy in adult patients with newly diagnosed glioblastoma: the phase Ib/II GEINO 1602 trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Vaz-Salgado, MA, Del Barco, S, Sepúlveda, JM, Alonso, M, Pineda, E, Balana, C, Martínez-García, M, Gironés, R

The hedgehog pathway is implicated in resistance to anticancer therapies in glioblastoma (GB). GEINO1602 (NCT03466450) phase Ib/II study evaluated the safety and efficacy of glasdegib and the Stupp scheme in newly diagnosed GB. Patients received glasdegib with radiotherapy plus concomitant and 6 cycles of adjuvant temozolomide followed by glasdegib monotherapy. The recommended phase 2 dose was 75 mg/day of glasdegib. The primary endpoint was the 15-months overall survival (OS), with a futility…



Projecting changes in demographics and causes of death people with HIV in western Europe from 2025 to 2050 a mathematical modelling study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ambia, J, van Sighem, A, Pantazis, N, Gill, MJ, Grabar, S, Monforte, AD, Zangerle, R, Bruguera, A, Teira, R, Jarrin, I, Vehreschild, J, Cavassini, M, van der Valk, M, Bonnet, F, Sterne, JAC, Ingle, SM, Trickey, A

Background Antiretroviral therapy (ART) scale-up in western Europe has reduced the incidence of AIDS-related conditions, increased life expectancies, and led to an ageing population of people with HIV. We aimed to project cause-specific mortality patterns in western Europe by 2050 in the context of changes in demographics and ART use. Methods We used a deterministic compartmental model calibrated in a Bayesian framework. From 2010 to 2023, the model was parameterised and calibrated using…



Does perioperative FLOT increase cure rates in resectable esophageal adenocarcinoma? A mixture cure model analysis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Mateos, L, Jiménez-Fonseca, P, Gallego, J, Lecumberri, A, Custodio, A, de Castro, EM, San Gil, RH, Montes, AF, Limon, ML, Vidal-Tocino, R, Cano, JM, Robles, JL, Gil, M, Eyzaguirre, DA, Zafra, GM, Mérida-García, AJ, Fernández, AF, Fernández, PR, Hierro, C, Riesco, MC, Araque, MG, Martín, MR, Pimentel, P, Visa, L, Cerdá, P, Granja, M, Blanco, ABR, Gutiérrez, L, Carmona-Bayonas, A

BackgroundTranslating trial findings to real-world cure rates for resectable oesophageal and gastroesophageal junction (GEJ) adenocarcinoma is critical. Standard endpoints like disease-free survival (DFS) may not distinguish durable cures from delayed recurrences.MethodsThis analysis of the AGAMENON-SEOM registry (NCT04958720) compared perioperative chemotherapy versus neoadjuvant chemoradiotherapy (nCRT). We estimated cure rates and analysed DFS and overall survival (OS) using mixture cure…



Transcriptional network analysis of PTEN-protein-deficient prostate tumors reveals robust stromal reprogramming and signs of senescent paracrine communication

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Rondon-Lorefice, I, Lopez, JI, Ugalde-Olano, A, Zufiaurre, M, Astobiza, I, Martin-Martin, N, Bozal-Basterra, L, Garcia-Longarte, S, Zabala-Letona, A, Rey, S, Santos-Martin, A, Unda, M, Loizaga-Iriarte, A, Graupera, M, Nuciforo, P, Carracedo, A, Mendizabal, I

Among the extensive genomic alterations in prostate cancer, phosphatase and tensin homolog (PTEN) deletion stands out as one of the most consistently observed events. PTEN loss in prostate tumors is primarily associated with cancer-cell proliferation and survival through the activation of the phosphoinositide 3-kinase (PI3K)-protein kinase B (AKT)-mechanistic target of rapamycin (mTOR) (PI3K-AKT-mTOR) signaling pathway. However, the use of PTEN as a robust biomarker in clinical practice is…



Cabozantinib plus Atezolizumab in Advanced, Progressive Endocrine Malignancies: A Multicohort, Basket, Phase II Trial (CABATEN/GETNE-T1914)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Capdevila, J, Hernando, J, Molina-Cerrillo, J, Viñuales, MB, Garcia-Carbonero, R, Teulé, A, Custodio, A, Jimenez-Fonseca, P, Lopez, C, Hierro, C, Carmona-Bayonas, A, Alonso, V, Llanos, M, Sevilla, I, García-Alvarez, A, Alonso-Gordoa, T, Jiménez, IG, Anton-Pascual, B, Sánchez, AM, Grande, E

Purpose: Multikinase inhibitors have shown efficacy in endocrine neoplasms, and synergism with immune checkpoint inhibitors has been noted in other tumors.Patients and Methods: This is a prospective, multicenter, open-label, Simon two-stage optimal design, phase II study including patients with advanced and refractory endocrine and neuroendocrine neoplasms in six cohorts: lung well-differentiated neuroendocrine tumors, anaplastic thyroid cancer (ATC), adrenocortical carcinoma (ACC),…



Policy Pressures and Inequality: The Challenges Facing Adolescent Health in Times of Crisis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Fortes-Muñoz, P, Espelt, A, Bosque-Prous, M, Folch, C, Robles-Muñoz, M, Drou-Roget, G, Teixido-Compaño, E, Pons-Vigués, M, Llosada-Gistau, J, Muntaner, C

Austerity measures following the 2007 financial crisis, along with the economic and social challenges imposed by the COVID-19 pandemic, have profoundly affected the living conditions of adolescents and their families, influencing their experiences and opportunities. This study aimed to examine socioeconomic position (SEP) inequalities across various health-related conditions among adolescents aged 12 to 19 years in central Catalonia. This cross-sectional study utilized data from a cohort of…



Biomolecular Fingerprints of Sirtuin Activity in Senescent Fibroblasts Identified via Synchrotron-Based FTIR

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Fernández-Duran, I, Ducic, T, Vaquero, A

Sirtuins are NAD+-dependent enzymes widely implicated in organismal ageing. In particular, nuclear-located sirtuins are histone deacetylases and/or monoADPrybosiltransferases that exert key roles in maintaining genomic stability. Although sirtuins have been reported to play an inhibitory role in cellular senescence, their specific targets and underlying mechanisms remain poorly understood. In this study, we use single-cell Synchrotron radiation-based Fourier-transform infrared spectroscopy…



2025 Focused Update of the 2019 ESC/EAS Guidelines for the management of dyslipidaemias

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Mach, F, Koskinas, KC, Lennep, JERV, Tokgozoglu, L, Badimon, L, Baigent, C, Benn, M, Binder, CJ, Catapano, AL, De Backer, GG, Delgado, V, Fabin, N, Ference, BA, Graham, IM, Landmesser, U, Laufs, U, Mihaylova, B, GrOnne, B, Richter, DJ, Sabatine, MS




EWS::FLI1 expression in human embryonic mesenchymal stem cells leads to transcriptional reprograming, defective DNA damage repair and Ewing sarcoma

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Hernández-Muñoz, I, Cuervas, I, Prada, E, Pulecio, J, Gimeno, R, Andrades, E, Gómez-González, S, Berenguer-Molins, P, Acedo-Terrades, A, Perera-Bel, J, Bódalo-Torruella, M, Nonell, L, Pérez, E, Grases, D, Mata, C, Yélamos, J, Richaud-Patin, Y, Vidal, E, Cuartero, Y, Le Dily, F, Suñol, M, Manzanares, A, Raya, A, Mora, J

Ewing sarcoma (ES) is an aggressive bone and soft tissue neoplasm characterized by EWSR::ETS rearrangements whose cellular origin remains unclear. EWS::FLI1 expression in human pediatric mesenchymal stem cells (MSCs) induces a transcriptional response distinct from that of human adult MSCs, but fails to form tumors. Here we show that EWS::FLI1 expression in human embryonic mesenchymal stem cells (heMSCs) results in the acquisition of an ES transcriptome, with the oncogene not preferentially…



Advances in Lung Cancer Basic and Translational Research in 2025-Overview and Perspectives Focusing on NSCLC

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Mascaux, C, Sen, T, Sanchez-Cespedes, M, Ortiz-Cuaran, S, Bossé, Y, Dammeijer, F, Cavic, M, Barr, MP, Arulananda, S, Armisen, R, Berger, AH, Bianchi, F, Carbone, DP, Cerciello, F, Lockwood, WW, Mitsudomi, T, Ohara, S, Politi, K, Qin, SD, Roisman, LC, Samstein, R, Skoulidis, F, Tan, AC, Thomas, A, Zhang, JJ, Wynes, MW, John, T, Tsao, MS

Basic and translational research in lung cancer is a rapidly evolving field with a transformational impact on early detection, diagnosis, therapeutic development, and personalization of care. Recent advances have greatly increased our understanding of the molecular genomics, proteomics, pathogenesis, and cellular biology of this deadly malignancy. The International Association for the Study of Lung Cancer (IASLC) recently formed a Basic and Translational Science (BaTS) Committee to further…



Real-world drug survival of tildrakizumab for plaque psoriasis: a 3-year international multicentre retrospective study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Torres, T, Sood, S, Yilmaz, O, Vender, RB, Prajapati, V, Puig, L, Megna, M, Marzano, AV, Gisondi, P, Carrascosa, JM, Dauden, E, Llamas-Velasco, M, Balato, A, Leal, BG, Prignano, F, Bellinato, F, Silvi, G, Di Brizzi, E, Potestio, L, Sechi, A, Carrera, CG, López-Ferrer, A, Del-Alcazar, E, Mufti, A, Maul, LV, Piaserico, S, Maul, JT, Yeung, J

Tildrakizumab is a monoclonal antibody targeting interleukin-23 that has gained regulatory approval for moderate-to-severe plaque psoriasis in several jurisdictions. While phase III clinical trials have evaluated its short-term efficacy and safety, real-world evidence regarding its long-term retention is limited. We report real-world drug survival of tildrakizumab in the routine clinical setting.



Cellular and humoral response after mRNA SARS-CoV-2 vaccination in kidney transplant recipients living with HIV: A cross-sectional study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Cacho, J, Nomah, DK, Egri, N, Cofán, F, Marcos, MA, Mosquera, M, Sanchez-Palomino, S, Bruguera, A, Esforzado, N, Bodro, M, Rovira, C, Hurtado, C, Vilella, A, Diekmann, F, Moreno, A, Miro, JM, Cucchiari, D

Introduction No data exists on responses to mRNA vaccines in kidney transplant recipients (KTRs) with HIV. We compared these responses in HIV-positive (HIV+KTR+) and negative KTRs (HIV-KTR+), and in people living with HIV (PLWH) without kidney transplantation (HIV+KTR-).Methods In across-sectional study of 33 patients receiving mRNA SARS-CoV-2 vaccination, we evaluated the humoral response to mRNA SARS-CoV-2 vaccination using a Luminex platform (IgG and IgM), and cellular response with specific…



Machine learning in Alzheimer's disease genetics

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Bracher-Smith, M, Ulm, B, Bellenguez, C, Grenier-Boley, B, Duroux, D, Nevado, AJ, Holmans, P, Tijms, BM, de Rojas, I, Campos-Martin, R, van der Lee, S, Castillo, A, Kuçukali, F, Peters, O, Schneider, A, Dichgans, M, Rujescu, D, Scherbaum, N, Deckert, J, Riedel-Heller, S, Hausner, L, Molina-Porcel, L, Düzel, E, Grimmer, T, Wiltfang, J, Heilmann-Heimbach, S, Moebus, S, Tegos, T, Scarmeas, N, Dols-Icardo, O, Moreno, F, Pérez-Tur, J, Bullido, MJ, Pastor, P, Alvarez, V, Rodriguez-Rodriguez, E, Soininen, H, de Mendonça, A, Mehrabian, S, Hort, J, Vyhnalek, M, Sandau, N, Thomassen, JQ, Pijnenburg, YAL, Holstege, H, van Swieten, J, Ramakers, I, Verhey, F, Scheltens, P, Graff, C, Papenberg, G, Giedraitis, V, Williams, J, Amouyel, P, Boland, A, Deleuze, JF, Nicolas, G, Dufouil, C, Pasquier, F, Hanon, O, Debette, S, Grünblatt, E, Popp, J, Solfrizzi, V, Parnetti, L, Squassina, A, Tremolizzo, L, Borroni, B, Nacmias, B, Spallazzi, M, Seripa, D, Rainero, I, Jessen, F, Kehoe, P, Magda, T, Sánchez-Juan, P, Sleegers, K, Ingelsson, M, Hiltunen, M, Sims, R, van der Flier, W, Andreassen, OA, Ruiz, A, Ramirez, A, Frikke-Schmidt, R, Amin, N, Roshchupkin, G, Lambert, JC, Van Steen, K, van Duijn, C, Escott-Price, V, Jansen, I, Andrade, V, Fernández, V, Dalmasso, MC, Kleineidam, L, Ahmad, S, Aarsland, D, Cano, A, Abdelnour, C, Alarcón-Martín, E, Alcolea, D, Alegret, M, Alvarez, I, Armstrong, NJ, Anthoula, T, Appollonio, I, Arcaro, M, Archetti, S, Pastor, AA, Athanasiu, L, Bailly, H, Banaj, N, Baquero, M, Pastor, AB, Berr, C, Besse, C, Bessi, V, Binetti, G, Bellini, S, Bizarro, A, Blesa, R, Boada, M, Boschi, S, Bossù, P, Bråthen, G, Bresner, C, Brodaty, H, Brookes, KJ, Buiza-Rueda, D, Bûrger, K, Burholt, V, Calero, M, Chene, G, Carracedo, A, Cecchetti, R, Cervera-Carles, L, Charbonnier, C, Chillotti, C, Ciccone, S, Claassen, JAHR, Clarimon, J, Clark, C, Conti, E, Corma-Gómez, A, Giuffrè, GM, Custodero, C, Daian, D, Dardiotis, E, Dartigues, JF, de Deyn, PP, del Ser, T, Denning, N, Diehl-Schmid, J, Diez-Fairen, M, Rossi, PD, Djurovic, S, Duron, E, Engelborghs, S, Blázquez, J, Ewers, M, Fabrizio, T, Nielsen, SF, Farotti, L, Fenoglio, C, Fernández-Fuertes, M, Ferreira, CB, Ferri, E, Fin, B, Fischer, P, Fladby, T, Fliessbach, K, Fortea, J, Foroud, T, Fostinelli, S, Fox, NC, Franco-Macías, E, Frank-García, A, Froelich, L, García-Alberca, JM, García-González, P, Garcia-Madrona, S, Garcia-Ribas, G, Giegling, I, Giorgio, G, Goldhardt, O, González-Pérez, A, Grande, G, Green, E, Grünblatt, E, Guetta-Baranes, T, Haapasalo, A, Hadjigeorgiou, G, Hampel, H, Hardy, J, Hartmann, AM, Leonenko, G, Harwood, J, Helisalmi, S, Heneka, MT, Hernández, I, Herrmann, MJ, Hoffmann, P, Holmes, C, Vilas, RH, Hulsman, M, Biessels, GJ, Johansson, C, Kilander, L, Ståhlbom, AK, Kivipelto, M, Koivisto, A, Kornhuber, J, Kosmidis, MH, Lage, C, Laukka, EJ, Lauria, A, Lehtisalo, J, Lerch, O, Lleó, A, de Munain, AL, Love, S, Löwemark, M, Luckcuck, L, Macias, J, MacLeod, CA, Maier, W, Mangialasche, F, Marco, S, Marquié, M, Marshall, R, Montes, AM, Rodríguez, CM, Mead, S, Medina, M, Meggy, A, Mendoza, S, Menéndez-González, M, Mol, M, Montrreal, L, Morgan, K, Nöthen, MM, Ngandu, T, Nordestgaard, BG, Olaso, R, Orellana, A, Orsini, M, Capdevila, M, Padovani, A, Paolo, C, Martinez-Lucas, M, Pericard, P, Pineda, JA, Pisanu, C, Polak, T, Posthuma, D, Priller, J, Puerta, R, Quenez, O, Quintela, I, Rábano, A, Reinders, MJT, Riederer, P, Olivé, C, Rongve, A, Allende, IR, Rosende-Roca, M, Royo, JL, Rubino, E, Sáez, ME, Sakka, P, Saltvedt, I, García-Gutierrez, F, Sánchez-Arjona, MB, Sanchez-Garcia, F, Sánchez-Valle, R, Sando, SB, Scamosci, M, Scarpini, E, Scherer, M, Schmid, M, Schott, JM, Selbæk, G, Shadrin, AA, Skrobot, O, Solomon, A, Sorbi, S, Sotolongo-Grau, O, Spottke, A, Stordal, E, Miguel, A, Tárraga, L, Tesí, N, Thalamuthu, A, Thomas, T, Traykov, L, Tybjærg-Hansen, A, Uitterlinden, A, Ullgren, A, Ulstein, I, Valero, S, Van Broeckhoven, C, Van Dongen, J, van Rooij, J, Vandenberghe, R, Vidal, JS, Vita, MG, Vogelgsang, J, Wagner, M, Wallon, D, Weinhold, L, Windle, G, Woods, B, Yannakoulia, M, Zulaica, M, Ghanbari, M, Sachdev, P, Mather, K, Ikram, MA, Melograna, F, Heikkinen, S, Arosio, B, Masullo, C, Real, LM, Piñol-Ripoll, G, Galimberti, D, Piras, F, Garcia-Alberca, JM, Mecocci, P, Rossi, G, Mir, P, Ghidoni, R, Daniele, A

Traditional statistical approaches have advanced our understanding of the genetics of complex diseases, yet are limited to linear additive models. Here we applied machine learning (ML) to genome-wide data from 41,686 individuals in the largest European consortium on Alzheimer's disease (AD) to investigate the effectiveness of various ML algorithms in replicating known findings, discovering novel loci, and predicting individuals at risk. We utilised Gradient Boosting Machines (GBMs),…



Transdermal delivery of enfuvirtide using dissolving microneedles integrated with novel insertion and removal indicator

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Li, HH, Vora, L, Li, YC, Pandya, AK, Wang, JW, Luo, YD, Abraham, AM, Ballana, E, Riveira, E, Nevot, M, Houghton, J, Mccarthy, HO, Donnelly, RF

Enfuvirtide, the first HIV fusion inhibitor, exhibits remarkable antiviral efficacy and a favourable safety profile compared with antiretroviral therapy alone. However, its clinical application is constrained by the necessity for subcutaneous administration and the high incidence of injection site reactions (ISRs) in 98 % of patients. This study seeks to overcome these limitations by developing dissolving microneedle array patches (DMAPs), offering a painless and efficient alternative for…



SIRT7 regulates NUCKS1 chromatin binding to elicit metabolic and inflammatory gene expression in senescence and liver aging

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Tran, KA, Gilbert, M, Vazquez, BN, Ianni, A, Garcia, BA, Vaquero, A, Berger, SL

Sirtuin enzymes are deeply associated with senescence and aging. Sirtuin proteins are tightly regulated, but how their levels are governed during aging and how they elicit tissue-specific cellular changes are unclear. Here, we demonstrate that SIRT7 undergoes proteasomal degradation during senescence via targeting by the E3 ligase TRIP12. We identified the transcription factor nuclear casein kinase and cyclin-dependent kinase substrate 1 (NUCKS1) as an interactor of SIRT7 and found NUCKS1…



Emerging mechanisms underlying formaldehyde toxicity and response

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Valverde-Santiago, M, Pontel, LB

Formaldehyde (FA) is an environmental pollutant and an endogenous metabolite produced in cells from central metabolic pathways. It rapidly reacts with electron-rich groups in biomolecules like nucleic acids and proteins, leading to cellular damage. Recent studies have revealed regulatory roles of FA in one-carbon metabolism, and its impact on cellular redox homeostasis and differentiation processes. Additionally, new insights have emerged into the molecular mechanisms underlying the repair of…



TET2-Mutant Clonal Hematopoiesis Promotes Heart Failure With Preserved Ejection Fraction

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Pandey, A, Thomas, T, Ji, YY, Kroger, B, Carlsgaard, P, Irion, CI, Kalkan, F, Segar, M, Subramanian, V, Bayés-Genís, A, Son, A, Young, KA, Trowbridge, JJ, Premnath, N, Jiang, N, Daou, D, Hu, WH, Ware, SA, Tong, D, Chung, SS




Epitope mapping of SARS-CoV-2 Spike protein using naturally-acquired immune responses to develop monoclonal antibodies

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
López-Aladid, R, Bueno-Freire, L, Farriol-Duran, R, Porta-Pardo, E, Aguilar, R, Vidal, M, Jiménez, A, Cabrera, R, Vázquez, N, López-Gavín, A, Moncunill, G, Carrascal, M, García, T, Lozano, M, García-Basteiro, AL, Dobaño, C, Pazos, MD, Estevez, MC, Lechuga, LM, Torres, A, Fernández-Barat, L

COVID-19 vaccination strategies are already available almost worldwide. However, it is also crucial to develop new therapeutic approaches, especially for vulnerable populations that may not fully respond to vaccination, such as the immunocompromised. In this project, we predicted 25 B-cell epitopes in silico in the SARS-CoV-2 Spike (S) protein and screened these against serum and plasma samples from 509 COVID-19 convalescent patients. The aim was to identify those epitopes with the highest IgG…



Semi-Markov Multistate Modeling Approaches for Multicohort Event History Data

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Piulachs, X, Langohr, K, Besalú, M, Pallarès, N, Carratalà, J, Tebé, C, Melis, GG

Two Cox-based multistate modeling approaches are compared for modeling a complex multicohort event history process. The first approach incorporates cohort information as a fixed covariate, thereby providing a direct estimation of the cohort-specific effects. The second approach includes the cohort as a stratum variable, which offers an extra flexibility in estimating the transition probabilities. Additionally, both approaches may include possible interaction terms between the cohort and a given…



Multi-cohort cerebrospinal fluid proteomics identifies robust molecular signatures across the Alzheimer disease continuum

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ali, M, Western, D, Liu, MH, Beric, A, Budde, J, Do, A, Heo, G, Wang, LH, Gentsch, J, Schindler, SE, Morris, JC, Holtzman, DM, Ruiz, A, Alvarez, I, Aguilar, M, Pastor, P, Rutledge, J, Oh, H, Wilson, EN, Le Guen, Y, Khalid, RR, Robins, C, Pulford, DJ, Tarawneh, R, Ibanez, L, Wyss-Coray, T, Sung, YJ, Cruchaga, C, Timsina, J

Changes in b-amyloid (Ab) and hyperphosphorylated tau (T) in brain and cerebrospinal fluid (CSF) precede Alzheimer's disease (AD) symptoms, making the CSF proteome a potential avenue to understand disease pathophysiology and facilitate reliable diagnostics and therapies. Using the AT framework and a three-stage study design (discovery, replication, and meta-analysis), we identified 2,173 analytes (2,029 unique proteins) dysregulated in AD. Of these, 865 (43%) were previously reported, and…



Cardiac rhythm devices in heart failure with reduced ejection fraction - role, timing, and optimal use in contemporary practice. European Journal of Heart Failure expert consensus document

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Bozkurt, B, Mullens, W, Leclercq, C, Russo, AM, Savarese, G, Böhm, M, Hill, L, Kinugawa, K, Sato, N, Abraham, WT, Bayes-Genis, A, Mebazaa, A, Rosano, GMC, Zieroth, S, Linde, C, Butler, J

Guidelines for management of heart failure with reduced ejection fraction (HFrEF) emphasize personalized care, patient engagement, and shared decision-making. Medications and cardiac rhythm management (CRM) devices are recommended with a high level of evidence. However, there are significant disparities: patients who could benefit from devices are frequently referred too late or not at all. Misconceptions about device therapy and the notion that the needs of patients (especially the prevention…



Hyperprolactinemia in drug-naïve first episode psychosis and its association with BDNF levels

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Toll, A, Bergé, D, Martínez-Sadurní, L, Trabsa, A, Perez-Sola,, Mané, A

Background and Objectives: Hyperprolactinemia is a common and well-known side effect of antipsychotic treatment. However, prolactin levels are elevated in drug-na & iuml;ve first-episode psychosis (FEP) patients, which suggests that the association between prolactin and psychosis may be more complex than previously thought. One possible hypothesis to explain this association is that prolactin has a neuroprotective effect mediated by BDNF. Methods: 50 drug- na & iuml;ve FEP were included…



DSTYK Inhibition Sensitizes NSCLC to Taxane-Based Chemotherapy

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Echepare, M, Picabea, B, Arricibita, A, Teijeira, A, Pasquier, A, Zandueta, C, Otegui, N, Santamaría, E, Fernández-Irigoyen, J, Romero, O, Sanchez-Cespedes, M, Lecanda, F, Hernández, J, Felip, E, Cruz-Bermúdez, A, Provencio, M, Gentili, M, Facchinetti, F, Roz, L, Montuenga, LM, Valencia, K

Introduction: Chemotherapy continues to be the standard treatment for patients noneligible for targeted or immune- based therapies; nevertheless, treatment resistance remains a major clinical challenge. We previously found that expression levels of DSTYK, a poorly explored dual serine/ threonine and tyrosine kinase frequently amplified in cancer, identified patients with lung cancer exhibiting poor response to immune checkpoint inhibitors, and found that its inhibition sensitizes to…



Attenuated growth factor signaling during cell death initiation sensitizes membranes towards peroxidation

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Gollowitzer, A, Pein, H, Rao, ZG, Waltl, L, Bereuter, L, Loeser, K, Meyer, T, Jafari, V, Witt, F, Winkler, R, Su, FT, Grosse, S, Thürmer, M, Grander, J, Hotze, M, Harder, S, Espada, L, Magnutzki, A, Gstir, R, Weinigel, C, Rummler, S, Bonn, G, Pachmayr, J, Ermolaeva, M, Harayama, T, Schlüter, H, Kosan, C, Heller, R, Thedieck, K, Schmitt, M, Shimizu, T, Popp, J, Shindou, H, Kwiatkowski, M, Koeberle, A

Cell death programs such as apoptosis and ferroptosis are associated with aberrant redox homeostasis linked to lipid metabolism and membrane function. Evidence for cross-talk between these programs is emerging. Here, we show that cytotoxic stress channels polyunsaturated fatty acids via lysophospholipid acyltransferase 12 into phospholipids that become susceptible to peroxidation under additional redox stress. This reprogramming is associated with altered acyl-CoA synthetase isoenzyme…



Optimal timing for initiating first-line palliative systemic therapy in asymptomatic metastatic esophagogastric cancer: Insights from a European Delphi study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Kamp, D, May, AM, Adenis, A, Capela, A, Derks, S, De Felice, F, Dovnik, NF, Hierro, C, Ilhan-Mutlu, A, Lordick, F, Obermannova, RL, Petrillo, A, Puccini, A, Raimundo, A, Roviello, G, Siebenhüner, A, Slingerland, M, Smyth, EC, Laarhoven, HWMV, Mohammad, NH

Background: The enhanced application of imaging techniques is resulting in the diagnosis of more patients with asymptomatic metastatic esophagogastric cancer (mEGC). We conducted a Delphi study to gather insights from European experts on the optimal timing for initiating palliative systemic therapy for these patients. Methods: An online survey featured 14 scenarios where physicians chose their preferred timing for initiating systemic therapy: immediate(<3 weeks) or deferred. The standard…



Clostridioides difficile infection and recurrence in cancer patients (CIRCA): A multicentre, international study

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Puerta-Alcalde, P, O'Keefe, J, Woolstencroft, R, Kaul, S, López, N, Cronin, K, Lim, A, Garcia-Pouton, N, Alvarez, M, Chee, L, Espasa, M, Grafia, I, Suárez-Lledó, M, Smibert, O, Garcia-Vidal, C, Slavin, MA, Yong, MK, Soriano, A, Worth, LJ

Objectives: We aimed to describe the characteristics of Clostridioides difficile infection (CDI) in cancer patients, analysing risk factors for 90-day recurrence and attributable mortality. Methods: Retrospective analysis on all CDI episodes from 2020 to 2022 in three Australian hospitals and one Spanish hospital. Logistic regression analyses were performed. Results: A total of 547 CDI episodes in cancer patients were documented. Treatment predominantly involved vancomycin (81.5%), followed by…



YPEL2 regulates the efficacy of BRD4-EZH2 dual targeting in EZH2Y641mut germinal center-derived lymphoma

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Chamorro-Jorganes, A, Profitós-Pelejà, N, Recasens-Zorzo, C, Valero, J, Reyes-Garau, D, Magnano, L, Butler, R, Postigo, A, Pérez-Galán, P, Ribeiro, ML, Roué, G

A significant proportion of diffuse large B cell lymphoma (DLBCL) and follicular lymphoma (FL) cases harbor a gain-of-function, heterozygous somatic mutation of the methyltransferase gene EZH2. While this factor is known to cooperate with the proto-oncogene MYC during malignant B cell development, the effect of interfering with both factors remains underexplored. Here we undertook the simultaneous evaluation of two epigenetic drugs targeting EZH2 methyltransferase activity and BRD4-mediated…



BET inhibitors downregulate the expression of the essential lncRNA SMILO in multiple myeloma through regulation of the transcription factor FLI1

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Gomez-Echarte, N, San Jose-Eneriz, E, Carrasco-Leon, A, Barrena, N, Miranda, E, Garate, L, Garcia-Torre, B, Alonso-Moreno, S, Gimenez-Camino, N, Urizar-Compains, E, Olaverri-Mendizabal, D, Aguirre-Ruiz, P, Ariceta, B, Tamariz-Amador, LE, Rodriguez-Otero, P, Planes, FJ, Belver, L, Martin-Subero, JI, Prosper, F, Agirre, X




Nurse management of minor problems in primary care emergencies: a non-randomized controlled trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Estarlich-Corominas, J, Soler-Abril, N, Casanellas-Chuecos, A, Becerra-Corzo, S, Bianco, AS, Toran-Monserrat, P, García-Sierra, R

BackgroundHealth systems must implement strategies to adapt to the high demand in primary care caused by social changes. Since 2009, the Catalan Institute of Health has been expanding the Nurse Demand Management programme through which nursing autonomously addresses minor health problems. This study aims to analyse whether this programme is a factor in improving the efficiency and quality of care in a primary care emergency centre. The results come from a non-randomised controlled experimental…



BELANTAMAB MAFODOTIN plus BORTEZOMIB plus DEXAMETHASONE (BVD) VS DARATUMUMAB plus VD (DVD) IN RRMM: UPDATES ON OVERALL SURVIVAL (OS) AND EFFICACY IN DREAMM-7

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Dimopoulos, M, Hungria, V, Robak, P, Hus, M, Zherebtsova, V, Ward, C, Ho, P, Hajek, R, Kim, K, Grosicki, S, Sia, H, Bryant, A, Lacerda, M, Martinez, G, Balarí, A, Sandhu, I, Cerchione, C, Ganly, P, Fu, C, Garg, M, Abdallah, AO, Gatt, M, Oriol, A, Cavo, M, Rifkin, R, Fujisaki, T, Mielnik, M, Pirooz, N, Lee, J, Mckeown, A, Rogers, R, Baig, H, Eccersley, L, Roy-Ghanta, S, Opalinska, J, Mateos, M




PHASE 3 RANDOMIZED STUDY OF DARATUMUMAB (DARA) MONOTHERAPY VERSUS ACTIVE MONITORING IN PATIENTS (PTS) WITH HIGH-RISK SMOLDERING MULTIPLE MYELOMA (SMM): PRIMARY RESULTS OF THE AQUILA STUDY

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Dimopoulos, MA, Voorhees, PM, Schjesvold, F, Cohen, YC, Hungria, V, Sandhu, I, Lindsay, J, Baker, RI, Suzuki, K, Kosugi, H, Levin, M, Beksac, M, Stockerl-Goldstein, K, Oriol, A, Mikala, G, Garate, G, Theunissen, K, Spicka, I, Mylin, AK, Bringhen, S, Uttervall, K, Pula, B, Medvedova, E, Cowan, AJ, Moreau, P, Mateos, MV, Goldschmidt, H, Ahmadi, T, Sha, L, Rousseau, E, Li, L, Dennis, RM, Carson, R, Rajkumar, SV




OVERALL SURVIVAL (OS) WITH CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) VERSUS STANDARD OF CARE (SOC) IN LENALIDOMIDE (LEN)-REFRACTORY MULTIPLE MYELOMA (MM): PHASE 3 CARTITUDE-4 STUDY UPDATE

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Leleu, X, San-Miguel, J, Mateos, MV, Dhakal, B, Touzeau, C, Van de Donk, NWCJ, Sidana, S, Oriol, A, Cohen, YC, Harrison, SJ, Einsele, H, Corradini, P, Chen, D, Li, Q, Li, K, Slaughter, A, Lonardi, C, Benachour, N, Vogel, M, Lendvai, N, Koneru, M, Patel, N, Florendo, E, Ho, PJ, Popat, R




STEM-CELL MOBILIZATION AND TRANSPLANTATION IN PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA TREATED WITH CARFILZOMIB-LENALIDOMIDE-DEXAMETHASONE WITH OR WITHOUT ISATUXIMAB (EMN24 ISKIA TRIAL)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Mina, R, Gay, F, Roeloffzen, W, Dimopoulos, MA, Rosiñol, L, Van der Klift, M, Oriol, A, Katodritou, E, Wu, KL, Rodriguez-Otero, P, Hájek, R, Attucci, I, Van Duin, M, D'agostino, M, Grasso, M, Ypma, P, De Jonge-Peeters, S, Straub, J, Casaluci, GM, Westerman, M, Engelhardt, M, Tosi, P, Regelink, J, Schjesvold, F, Bladé, J, Einsele, H, Sonneveld, P, Boccadoro, M, Broijl, A




CILTACABTAGENE AUTOLEUCEL (CILTA-CEL) VS STANDARD OF CARE (SOC) IN PATIENTS WITH LENALIDOMIDE (LEN)-REFRACTORY MULTIPLE MYELOMA (MM) AFTER 1-3 LINES OF THERAPY: MINIMAL RESIDUAL DISEASE NEGATIVITY (MRD-NEG) IN THE PHASE 3 CARTITUDE-4 TRIAL

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Oriol, A, Popat, R, Cavo, M, Karlin, L, Avivi, I, Roeloffzen, W, Kim, SJ, Lipe, B, Bar, N, Horvath, N, Spencer, A, Min, CK, Chen, D, Li, Q, Li, K, Slaughter, A, Lonardi, C, Benachour, N, Ghosh, A, Vogel, M, Lendvai, N, Lengil, T, Patel, N, Filho, OC, Florendo, E, Lin, Y




Transcutaneous electrical stimulation in chronic post-stroke oropharyngeal dysphagia: pooled biomechanical and kinematic analysis from a one-year randomized controlled clinical trial

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ortega, O, Palomeras, E, Clavé, P

Oropharyngeal dysphagia in chronic post-stroke (PS-OD) patients is associated with impaired oropharyngeal sensory/motor function. We aimed to evaluate the effect of transcutaneous electrical stimulation (TES) on the biomechanics and kinetics of swallowing in PS-OD patients in a randomized controlled clinical trial with 1-year follow-up. 71 PS-OD patients with impaired safety of swallow (ISS) were randomized into 2 groups, (1) 26 with compensatory treatment (CT): thickeners and texture-modified…



Clock gene influences on sleep quality and HPA axis in major depressive disorder

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Ferrer, A, Pelegrí, A, Labad, J, Sagués, T, Salvat-Pujol, N, de Arriba-Arnau, A, Menchon, JM, Palao, D, Costas, J, Carracedo, A, Soria, V

Background: Major Depressive Disorder (MDD) has been associated with disruptions in circadian rhythms and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. Circadian rhythms are regulated by "clock" genes, including BMAL1, which are also implicated in HPA axis function. This study aimed to examine the association between BMAL1 polymorphisms and sleep quality, their interactions with sex and MDD diagnosis, and their potential influence on HPA axis activity in MDD. Methods…



OSE2101 plus docetaxel or nivolumab as second-line therapy in metastatic non-small cell lung cancer (mNSCLC) progressing after first-line chemoimmunotherapy (Combi-TED)

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Mencarini, R, Dols, MAC, Pasello, G, Felip, E, Debieuvre, D, Minuti, G, Mascaux, C, Vanel, FR, Delmonte, A, Gori, S, Metro, G, Campelo, MRG, Viter, S, Borra, G, Brun, LP, Mazzoni, F, Mangiola, D, Guillemois, S, Land, L, Cappuzzo, F




Polygenic risk score of glycemic homeostasis, Type 2 Diabetes Mellitus and glycemic components in first episode psychosis

Repositorio: r-IGTP. Repositorio Institucional de Producción Científica del Instituto de Investigación Germans Trias i Pujol
Segura, AG, Verdolini, N, Valli, I, Garcia-Rizo, C, Diaz-Caneja, CM, Vieta, E, Mezquida, G, Lobo, A, Gonzalez-Pinto, A, Andreu-Bernabeu, A, Roldan, A, Martinez-Aran, A, Baeza, I, Mane, A, Labad, J, Müller, DJ, Guasch-Capella, N, Bernardo, M, Mas, S, Bioque, GM, Gonzalez, J, Andrés, P, Cavone, V, Corripio, I, Duque, A, Mar-Barrutia, L, Marin, J, De-la-Camara, C, Vaquero-Puyuelo, D, Rivero, O, Fabra, MJE, Trabsa, A, Legido, T, Forte, MF, Serra-Navarro, M, de la Serna, H, Castro-Fornielles, J, Contreras, F, García-Portilla, MP, González-Blanco, L, Echevarría, RS, Rabadán, AZ, Rodriguez-Jimenez, R, Martínez-Gras, I, Usall, J, Barajas, A, Sarro, S, Pomarol-Clotet, E, Ibañez, A, Cuesta, MJ

Objective: First episode of psychosis (FEP) is associated with glucose homeostasis abnormalities even before pharmacological intervention. Given inconclusive GWAS results regarding a direct genetic link between schizophrenia and type 2 diabetes mellitus (T2DM), we hypothesized that FEP patients may exhibit altered genetic risk for glycemic traits. We compared polygenic risk scores (PRS) for T2DM (PRST2DM), fasting glucose (PRSFG), and glycated hemoglobin (HbA1c) (PRSHbA1c) between FEP patients…